The same study by Hansford et al. identified CTNNA1, a gene that codes for α-catenin, as another culprit in HDGC, and that should be screened in patients where clinical suspicion is high but CDH1 genetic testing is unremarkable [4]. Here, CTNNA1 is linked to CDH1-related diffuse gastric and lobular breast cancer syndrome.